Weiyingqi Cui

428 total citations
11 papers, 298 citations indexed

About

Weiyingqi Cui is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Weiyingqi Cui has authored 11 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Weiyingqi Cui's work include FOXO transcription factor regulation (2 papers), Renal and related cancers (2 papers) and Cancer-related Molecular Pathways (2 papers). Weiyingqi Cui is often cited by papers focused on FOXO transcription factor regulation (2 papers), Renal and related cancers (2 papers) and Cancer-related Molecular Pathways (2 papers). Weiyingqi Cui collaborates with scholars based in Sweden, China and Singapore. Weiyingqi Cui's co-authors include Xiao‐Feng Sun, Zong‐Guang Zhou, Yugang Wen, Huamei Tang, Yushuai Mi, Senlin Zhao, Zhihai Peng, Yang Yu, Weiliang Jiang and Meng Zhang and has published in prestigious journals such as Journal of Clinical Investigation, International Journal of Radiation Oncology*Biology*Physics and Molecular Cancer.

In The Last Decade

Weiyingqi Cui

9 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiyingqi Cui Sweden	6	203	135	74	49	22	11	298
Yue‐Ju Li Taiwan	9	243 1.2×	174 1.3×	71 1.0×	29 0.6×	11 0.5×	11	326
Amin Ghorbani Iran	6	196 1.0×	139 1.0×	49 0.7×	21 0.4×	20 0.9×	7	264
Xian-Zi Yang China	8	225 1.1×	95 0.7×	95 1.3×	28 0.6×	17 0.8×	8	320
Verónica Moncho-Amor Spain	8	263 1.3×	128 0.9×	96 1.3×	34 0.7×	13 0.6×	15	366
Shaowen Jin China	7	253 1.2×	92 0.7×	57 0.8×	52 1.1×	10 0.5×	9	323
Yina Qiao China	7	324 1.6×	239 1.8×	88 1.2×	37 0.8×	13 0.6×	8	415
Xuetian Zhang China	8	242 1.2×	86 0.6×	66 0.9×	33 0.7×	10 0.5×	10	322
Guangxu Deng China	5	214 1.1×	140 1.0×	41 0.6×	33 0.7×	14 0.6×	5	279
Xuebing Jia China	12	195 1.0×	121 0.9×	58 0.8×	51 1.0×	9 0.4×	17	293
Tugs‐Saikhan Chimed United States	8	184 0.9×	85 0.6×	143 1.9×	79 1.6×	20 0.9×	9	304

Countries citing papers authored by Weiyingqi Cui

Since Specialization

Citations

This map shows the geographic impact of Weiyingqi Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyingqi Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyingqi Cui more than expected).

Fields of papers citing papers by Weiyingqi Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyingqi Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyingqi Cui. The network helps show where Weiyingqi Cui may publish in the future.

Co-authorship network of co-authors of Weiyingqi Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyingqi Cui. A scholar is included among the top collaborators of Weiyingqi Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyingqi Cui. Weiyingqi Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Tong, Le, Weiyingqi Cui, Yaxuan Liu, et al.. (2025). VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and function. Cancer Immunology Immunotherapy. 74(9). 278–278.

Fonseca, Pedro, Weiyingqi Cui, Le Tong, et al.. (2024). A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells. Journal of Experimental & Clinical Cancer Research. 43(1). 107–107.

Tong, Le, Weiyingqi Cui, Boya Zhang, et al.. (2024). Patient-derived organoids in precision cancer medicine. Med. 5(11). 1351–1377. 38 indexed citations

Cui, Weiyingqi, Yuanyuan Zhang, Tomas Friman, et al.. (2023). Modulation of E-Cadherin Function through the AmotL2 Isoforms Promotes Ameboid Cell Invasion. Cells. 12(13). 1682–1682. 2 indexed citations

Cui, Weiyingqi, Ning Xie, Eric W.‐F. Lam, et al.. (2023). High expression of cytoplasmic FOXO3 protein associated with poor prognosis of rectal cancer patients: A study from Swedish clinical trial of preoperative radiotherapy to big database analysis. Heliyon. 9(5). e15342–e15342. 1 indexed citations

Cui, Weiyingqi, Pedro Fonseca, Yumeng Zhang, et al.. (2023). Deciphering the Role of p60AmotL2 in Epithelial Extrusion and Cell Detachment. Cells. 12(17). 2158–2158. 1 indexed citations

Yang, Ying, Shiyong Neo, Ziqing Chen, et al.. (2020). Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells. Journal of Clinical Investigation. 130(10). 5508–5522. 65 indexed citations

Liu, Na, Weiyingqi Cui, Xia Jiang, et al.. (2019). The Critical Role of Dysregulated RhoB Signaling Pathway in Radioresistance of Colorectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 104(5). 1153–1164. 22 indexed citations

Zhao, Senlin, Hongcheng Sun, Weiliang Jiang, et al.. (2017). miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition. Molecular Cancer. 16(1). 12–12. 66 indexed citations

10.

Mi, Yushuai, Dongyuan Zhang, Weiliang Jiang, et al.. (2016). miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation. Cancer Letters. 389. 11–22. 87 indexed citations

11.

Liu, Na, Thomas R. Cox, Weiyingqi Cui, et al.. (2016). Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients. Oncotarget. 8(36). 60015–60024. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact